Description
Phase
Phase 2 - takes the treatment one step further, assessing the activity of a particular therapy in a disease, often building upon leads from the Phase I trial. While patients are generally required to be previously untreated, participation in a Phase II trial doesn't usually preclude the patient from getting the standard treatment after they've received the investigational agent. At best they are allowed to get a new drug they wouldn't be able to get otherwise that may turn out to be better for their disease.Inclusion and Exclusion Criteria
Please contact Heberto Santos to learn more about the eligibility criteria for this trial. Please use the contact form on the right side.
Sites
-
California
- USC/Kenneth Norris Comprehensive Cancer Center USC, Los Angeles, California, 90033
- USC/Kenneth Norris Comprehensive Cancer Center USC, Los Angeles, California, 90033
-
Washington
- Compass Oncology, Vancouver, Washington, 98683
- Compass Oncology, Vancouver, Washington, 98683
-
Indiana
- Indiana Blood and Marrow Institute SC, Beach Grove, Indiana, 46107
- Indiana Blood and Marrow Institute SC, Beach Grove, Indiana, 46107
-
Germany
- Novartis Investigative Site, Ulm, 89081
- Novartis Investigative Site, Ulm, 89081
- Novartis Investigative Site, Heilbronn, 74072
- Novartis Investigative Site, Heilbronn, 74072
- Novartis Investigative Site, Duesseldorf, 40225
-
Mexico
- Novartis Investigative Site, San Luis Potosí, 78218
- Novartis Investigative Site, San Luis Potosí, 78218
-
Baden-Württemberg
- Novartis Investigative Site, Mannheim, Baden-Württemberg, 68305
- Novartis Investigative Site, Mannheim, Baden-Württemberg, 68305
-
Israel
- Novartis Investigative Site, Ramat Gan, 52621
- Novartis Investigative Site, Ramat Gan, 52621
-
France
- Novartis Investigative Site, Grenoble, 38043
- Novartis Investigative Site, Grenoble, 38043
- Novartis Investigative Site, Vandoeuvre les Nancy, 54511
- Novartis Investigative Site, Vandoeuvre les Nancy, 54511
-
Las Palmas de Gran Canaria
- Novartis Investigative Site, La Laguna, Las Palmas de Gran Canaria, 38320
- Novartis Investigative Site, La Laguna, Las Palmas de Gran Canaria, 38320